Display options
Cite
Furuya Y, Ludewick HP, Müllbacher A. Mysteries of type I IFN response: benefits versus detriments. Front Immunol. 2015;6:21doi: 10.3389/fimmu.2015.00021.
Furuya, Y., Ludewick, H. P., & Müllbacher, A. (2015). Mysteries of type I IFN response: benefits versus detriments. Frontiers in immunology, 621. https://doi.org/10.3389/fimmu.2015.00021
Furuya, Yoichi, et al. "Mysteries of type I IFN response: benefits versus detriments." Frontiers in immunology vol. 6 (2015): 21. doi: https://doi.org/10.3389/fimmu.2015.00021
Furuya Y, Ludewick HP, Müllbacher A. Mysteries of type I IFN response: benefits versus detriments. Front Immunol. 2015 Jan 28;6:21. doi: 10.3389/fimmu.2015.00021. eCollection 2015. PMID: 25674090; PMCID: PMC4309204.
Copy Download .nbib Format: NLM
Share it on

Front Immunol. 2015 Jan 28;6:21. doi: 10.3389/fimmu.2015.00021. eCollection 2015.

Mysteries of type I IFN response: benefits versus detriments.

Frontiers in immunology

Yoichi Furuya, Herbert P Ludewick, Arno Müllbacher

Affiliations

  1. Center for Immunology and Microbial Disease, Albany Medical College , Albany, NY , USA.
  2. Department of Immunology, The John Curtin School of Medical Research, Australian National University , Canberra, ACT , Australia.

PMID: 25674090 PMCID: PMC4309204 DOI: 10.3389/fimmu.2015.00021

[No abstract available.]

Keywords: bacterial; type I interferons; vaccine adjuvant; viral

References

  1. Front Immunol. 2014 Aug 29;5:412 - PubMed
  2. Front Microbiol. 2014 Oct 28;5:545 - PubMed
  3. PLoS One. 2011;6(10):e25765 - PubMed
  4. J Immunol. 2010 Apr 1;184(7):3755-67 - PubMed
  5. Front Immunol. 2014 Sep 11;5:431 - PubMed
  6. Ann N Y Acad Sci. 2007 Jun;1105:266-83 - PubMed
  7. Front Immunol. 2014 Jun 10;5:267 - PubMed
  8. Front Immunol. 2014 Oct 30;5:526 - PubMed
  9. Front Immunol. 2014 Sep 02;5:419 - PubMed
  10. Front Immunol. 2014 Jul 23;5:355 - PubMed

Publication Types